Skip to main content
logo
CanSino Biologics Inc. (HKG:6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.44
-0.12 (-0.36%)
At close: Feb 13, 2026

CanSino Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
12,70711,61012,51427,69066,11174,412
Market Cap Growth
17.30%-7.23%-54.81%-58.12%-11.15%466.94%
Enterprise Value
11,21410,30210,61123,86858,92068,404
Last Close Price
33.4431.5023.5566.75177.89174.24
PE Ratio
----28.13-
Forward PE
42.64---11.1625.30
PS Ratio
11.9612.8931.8123.6812.532517.38
PB Ratio
2.362.222.153.386.3010.32
P/TBV Ratio
2.452.282.213.756.8910.38
P/FCF Ratio
----63.60-
P/OCF Ratio
75.68---26.27-
EV/Sales Ratio
10.5611.4426.9720.4111.162314.14
EV/EBITDA Ratio
----25.96-
EV/EBIT Ratio
----26.91-
EV/FCF Ratio
-65.52---56.68-
Debt / Equity Ratio
0.290.410.510.370.160.02
Debt / EBITDA Ratio
----0.74-
Debt / FCF Ratio
----1.62-
Net Debt / Equity Ratio
-0.28-0.24-0.27-0.45-0.75-0.82
Net Debt / EBITDA Ratio
16.176.150.972.46-3.469.97
Net Debt / FCF Ratio
8.721.910.941.11-7.577.79
Asset Turnover
0.130.100.030.090.460.01
Inventory Turnover
0.710.831.551.572.480.16
Quick Ratio
3.242.381.862.332.7812.54
Current Ratio
3.622.542.022.643.2513.24
Return on Equity (ROE)
-2.84%-7.52%-31.40%-12.22%26.09%-10.52%
Return on Assets (ROA)
-1.87%-2.74%-10.36%-8.03%11.97%-7.58%
Return on Invested Capital (ROIC)
-6.46%-10.02%-43.85%-48.83%108.45%-52.23%
Return on Capital Employed (ROCE)
-3.70%-6.00%-25.50%-17.50%19.80%-8.20%
Earnings Yield
-1.22%-3.47%-13.05%-3.71%3.55%-0.63%
FCF Yield
-1.35%-5.73%-13.37%-11.95%1.57%-1.02%
Dividend Yield
----0.55%-
Payout Ratio
----0.74%-
Buyback Yield / Dilution
1.66%-0.38%0.17%0.08%-7.26%-13.46%
Total Shareholder Return
1.66%-0.38%0.17%0.08%-6.70%-13.46%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.